UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 7, 2012
Vitamin Shoppe, Inc.
(Exact name of registrant as specified in its charter)
| | | | |
Delaware | | 001-34507 | | 11-3664322 |
(State or Other Jurisdiction of Incorporation or Organization) | | (Commission File Number) | | (IRS Employer Identification No.) |
2101 91st Street
North Bergen, New Jersey 07047
(Addresses of Principal Executive Offices, including Zip Code)
(201) 868-5959
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 5.07 | Submission of Matters to a Vote of Security Holders. |
At the Vitamin Shoppe, Inc. (“the Company”) Annual Meeting of Stockholders held on June 7, 2012 (the “Annual Meeting”), our stockholders: (a) elected the persons listed below to serve as directors for a term of one year expiring at the 2013 Annual Meeting of Stockholders and until their successors are duly elected and qualified; (b) approved the compensation paid to the Company’s named executive officers; (c) approved the amendment and restatement of the 2009 Equity Incentive Plan, including performance goals; and (d) ratified the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the 2012 fiscal year. Set forth below are the voting results for each of these proposals:
a. | All of the director nominees were elected to serve until the Annual Meeting in 2013 and until their respective successors are duly elected and qualified. |
| | | | | | | | | | | | |
DIRECTOR | | VOTES FOR | | | VOTES WITHELD | | | BROKER NON-VOTES | |
Richard L. Markee | | | 25,398,652 | | | | 2,006,229 | | | | 728,564 | |
B. Michael Becker | | | 27,317,794 | | | | 87,807 | | | | 728,564 | |
Catherine E. Buggeln | | | 27,382,980 | | | | 21,901 | | | | 728,564 | |
John H. Edmondson | | | 27,316,894 | | | | 87,987 | | | | 728,564 | |
David H. Edwab | | | 26,814,572 | | | | 590,309 | | | | 728,564 | |
Richard L. Perkal | | | 26,561,716 | | | | 843,165 | | | | 728,564 | |
Beth M. Pritchard | | | 27,086,468 | | | | 318,413 | | | | 728,564 | |
Katherine Savitt-Lennon | | | 27,370,896 | | | | 33,985 | | | | 728,564 | |
Anthony N. Truesdale | | | 27,307,718 | | | | 97,163 | | | | 728,564 | |
b. | An advisory (non-binding) vote approved the executive compensation of our named executive officers. |
| | | | | | | | | | | | |
FOR | | AGAINST | | | ABSTAIN | | | BROKER NON-VOTES | |
27,539,819 | | | 143,389 | | | | 3,698 | | | | 362,281 | |
c. | Approval of Amendment and Restatement of the 2009 Equity Incentive Plan, including Performance Goals:. |
| | | | | | | | | | | | |
FOR | | AGAINST | | | ABSTAIN | | | BROKER NON-VOTES | |
25,192,182 | | | 2,195,259 | | | | 17,440 | | | | 728,564 | |
d. | The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2012 fiscal year was approved. |
| | | | | | | | |
FOR | | AGAINST | | | ABSTAIN | |
28,131,891 | | | 620 | | | | 934 | |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| | Vitamin Shoppe, Inc. |
| | |
Date: June 8, 2012 | | By: | | /s/ Jean Frydman |
| | Name: Jean Frydman |
| | Title: Vice President and General Counsel |